Clinical Trial Update: CardioCel Tri-leaflet Repair Study [NA]

View source ↗

Summary

A CardioCel Tri-leaflet Repair study by Anteris Technologies completed; the trial assessed outcomes for aortic stenosis and aortic insufficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Insufficiency
• Aortic Stenosis

Drugs mentioned

• CardioCel Tri-leaflet Repair

Snippet

Sponsor: Anteris Technologies Ltd. | Conditions: Aortic Stenosis, Aortic Insufficiency | NA | Status: COMPLETED